Clinical TrialsSearch results
Number of results: 2967
Other
- Phase I/II study of intravenous and intraperitoneal paclitaxel combined with continuous intraperitoneal cisplatin for advanced gastric cancer with peritoneal metastasis
- advanced gastric cancer with peritoneal metastasis
- Department of Surgical Oncology, The University of Tokyo
- 2009-08-01
Other
- A phase 1 study of the combination chemotherapy of sorafenib with cisplatin transcatheter arterial infusion for advanced hepatocellular carcinoma.
- advanced hepatocellular carcinoma
- National Cancer Center Hospital
- 2008-12-02
Other
- Phase I/II trial of hepatic arterial infusion of FMP therapy for advanced hepatocellular carcinoma
- advanced hepatocellular carcinoma
- Hepatobiliary and Pancreatic Oncology Division, National Cancer Center Hospital
- 2006-09-12
Other
- Multicenter Phase II Randomized Controlled Trial of S-1 and Interferon-alpha Combined Chemotherapy or S-1 Alone in Advanced Hepatocellular Carcinoma with Extrahepatic Metastasis
- Advanced hepatocellular carcinoma with extrahepatic metastasis
- Graduate School of Medicine, Osaka University Department of Surgery
- 2007-07-26
Other
- A phase II trial of hepatic arterial infusion chemotherapy with cisplatin for advanced hepatocellular carcinoma with portal vein tumor thrombosis
- Advanced hepatocellular carcinoma with portal vein tumor thrombosis
- Hepatobiliary and Pancreatic Oncology Division, National Cancer Center Hospital
- 2006-09-12
Not yet recruiting
- Beamion BCGC-1: A Phase Ib and Phase II trial of zongertinib in combination with intravenous trastuzumab deruxtecan (T-DXd) or in combination with intravenous trastuzumab emtansine (T-DM1) for treatment of patients with advanced HER2+ mBC and mGEAC
- Advanced HER2+ mBC and mGEAC
- Sila Aykut Yazgili
- 2024-06-03
Recruiting
- Imatinib and Pembrolizumab combination therapy for advanced KIT-mutant melanoma: a phase I/II trial (IMPAKT trial)
- Advanced KIT-mutant melanoma
- Funakoshi Takeru
- 2020-02-05
Recruiting
- BGB-A317-290-LTE1
- Advanced Malignancies
- IQVIA Services Japan G.K. jRCT Inquiry Contact
- 2023-06-24
Completed
- JCOG1213: Randomized phase III study of etoposide plus cisplatin combination therapy versus irinotecan plus cisplatin combination therapy in advanced neuroendocrine carcinoma of the digestive system.
- advanced neuroendocrine carcinoma of the digestive system
- OKUSAKA Takuji
- 2019-01-23
Recruiting
- First in human study of BAY2927088 in participants who have advanced non-small cell lung cancer (NSCLC) with mutations in the genes of epidermal growth factor receptor (EGFR) and/or human epidermal growth factor receptor 2 (HER2)
- Advanced Non-Small Cell Lung Cance
- Tanigawa Takahiko
- 2022-07-31